Skip to main content

Table 3 Median percentage changes in the investigated markers of ovarian reserve 3 months after supracervical hysterectomy, uterine artery embolization or after a course of UPA therapy

From: Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study

Variable

Study group

Percentage change at 3-month follow-up

P

Post-hoc analysis

AFC

Hysterectomy

−8.4 (− 15 – − 4.2)

< 0.001

Hysterectomy vs UPA: NS

UPA

−7.8 (−14.3–0)

 

Hysterectomy vs UAE: p < 0.001

UAE

− 63.4 (− 78.9 – − 37.5)

 

UPA vs UAE: p < 0.001

AMH

Hysterectomy

−3.5 (− 10–4.8)

< 0.001

Hysterectomy vs UPA: NS

UPA

−5.8 (− 7.7 – − 5.1)

 

Hysterectomy vs UAE: p < 0.001

UAE

− 61.9 (− 82 – − 47.4)

 

UPA vs UAE: p < 0.001

INH

Hysterectomy

−7.4 (−15.1 – − 2.5)

< 0.001

Hysterectomy vs UPA: NS

UPA

− 7.0 (− 10.6–3.0)

 

Hysterectomy vs UAE: p < 0.001

UAE

−60.7 (− 74.5 – − 51.2)

 

UPA vs UAE: p < 0.001

FSH

Hysterectomy

21.5 (−9.1–35)

< 0.001

Hysterectomy vs UPA: NS

UPA

12.7 (− 9.8–27)

 

Hysterectomy vs UAE: p < 0.001

UAE

125.6 (51–295.8)

 

UPA vs UAE: p < 0.001

E2

Hysterectomy

−13.3 (− 19.5 – − 3.5)

< 0.001

Hysterectomy vs UPA: NS

UPA

−3.3 (− 10.3–11.4)

 

Hysterectomy vs UAE: p < 0.001

UAE

−41 (−53.5–7.6)

 

UPA vs UAE: p < 0.001

  1. Data are presented as median (interquartile range). AFC antral follicle count, AMH anti-Mullerian hormone, INHB inhibin B, FSH follicle stimulating hormone, E2 estradiol, UPA ulipristal acetate, UAE uterine artery embolization